Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications

Since Doxil's first clinical approval in 1995, lipid nanoparticles have garnered great interest and shown exceptional therapeutic efficacy. It is clear from the licensure of two RNA treatments and the mRNA-COVID-19 vaccination that lipid nanoparticles have immense potential for delivering nucle...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	3 Biotech 2024-02, Vol.14 (2), p.57-57, Article 57
Hauptverfasser:	Dhayalan, Manikandan, Wang, Wei, Riyaz, S. U. Mohammed, Dinesh, Rakshi Anuja, Shanmugam, Jayashree, Irudayaraj, Santiagu Stephen, Stalin, Antony, Giri, Jayant, Mallik, Saurav, Hu, Ruifeng
Format:	Artikel
Sprache:	eng
Schlagworte:	Agriculture Aqueous solutions Biocompatibility Bioinformatics Biomaterials Biotechnology Cancer Research Chemistry Chemistry and Materials Science COVID-19 Drug delivery drugs Emulsification emulsifying emulsions Flow charts Glioblastoma High pressure Homogenization Lipids Liposomes mRNA nanocarriers Nanoparticles Nucleic acids Rapamycin Review Article RNA Solvents Stem Cells Therapeutic applications Toxicity Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!